Bavarian Nordic is an international biotechnology headquartered in Denmark. Read the full story

ARTES Biotechnology and Burnet Institute have joined forces to develop a new type of malaria vaccine in a project funded by the PATH Malaria Vaccine Initiative (MVI). Read the full story

MicuRx Pharmaceuticals announced it raised $25 million in Series B financing. Read the full story

3-V Biosciences announced the completion of a Series C financing round, raising $20 million. Read the full story

The Malaria Partnering provides understanding and access to the malaria partnering deals and agreements entered into by the worlds leading healthcare companies Read the full story

The Dengue Fever Partnering provides understanding and access to the dengue fever partnering deals and agreements entered into by the worlds leading healthcare companies Read the full story

The Tropical Diseases Partnering provides understanding and access to the tropical diseases partnering deals and agreements entered into by the worlds leading healthcare companies Read the full story

The Fungal Partnering provides understanding and access to the fungal partnering deals and agreements entered into by the worlds leading healthcare companies Read the full story

The Parasitic Partnering provides understanding and access to the parasitic partnering deals and agreements entered into by the worlds leading healthcare companies Read the full story

The RSV Partnering provides understanding and access to the RSV partnering deals and agreements entered into by the worlds leading healthcare companies Read the full story